Browsing by Subject "antibody-drug conjugate"
Now showing items 1-1 of 1
-
(2018-11-27)HER2-postive breast cancer constitutes approximately 25% of breast cancer patients and leads to a worse prognosis. Antibody therapy, such as the anti-HER2 antibody trastuzumab, is used in the clinical setting to treat these ...